Xianjue Bio's VascularizedLung Cancer Organoid Model Precisely Decodes Tumor-Vascular Interactions

Lung cancer, a highly prevalent malignant tumor, is characterized by complex tumor microenvironments where the interaction between tumors and blood vessels is a key factor in disease progression and the development of drug resistance. However, traditional research models struggle to replicate the in vivo vascular-tumor interaction characteristics, frequently hindering lung cancer mechanism research and drug development.
The vascularized lung cancer organoid model developed by Xianjue Bio, leveraging its core vascularization microphysiological technology, precisely replicates the clinical patterns of tumor-vascular interaction in lung cancer. It provides a highly biomimetic in vitro research platform for lung cancer basic research, anti-angiogenic drug screening, and individualized diagnosis and treatment, making lung cancer research closer to the actual clinical state!
High Biomimicry, Replicating Clinical Characteristics of Lung Cancer Vascular-Tumor Interactions
Xianjue Bio's lung cancer organoid vascularization model, not simply co-culturing lung cancer organoids with vascular cells, but through the cross-scale integration of biological 3D printing and microfluidic chips, constructs a perfusable functional vascular network. Combined with patient-derived lung cancer organoids, it achieves an in vitro precise replication of the in vivo tumor-vascular microenvironment, with its core features highly consistent with clinical observations:
✅ Tumor density positively correlates with vascular degeneration: In the model, as tumor density increases, the degeneration of surrounding vascular networks becomes more pronounced, accurately replicating the pathological reality of vascular dysfunction and network degeneration in densely populated tumor areas in clinical lung cancer. This allows in vitro studies to directly correspond to in vivo tumor progression status;
✅ Dynamic changes in the vascularized network: Under a dynamic culture system, the model can achieve stable culture of the vascularized network for over 21 days. It clearly observes the dynamic evolution of the vascular network within the biomimetic gel system from dense to sparse after co-culturing with tumor cells, perfectly reproducing the tumor's remodeling process of the vascular microenvironment;
✅ Replicating lung cancer heterogeneity: In the model, some lung cancer organoids can recruit vessels to form tightly interwoven structures, while others appear as isolated masses without vascular recruitment. Loosely structured organoids facilitate vascular invasion, while vesicular dense structures impede vascular penetration, showing high consistency with the structural and vascular recruitment heterogeneity of clinical lung cancer, thus addressing the pain point of traditional models' "uniformity" failing to reflect clinical reality.
Empowered by core technologies, making the model more valuable for research and clinical applications
The high biomimicry and reliability of Xianjue Bio's lung cancer organoid vascularization model stem from the deep empowerment of the company's unique three-in-one technology platform: vascularization + immune microenvironment + AI closed-loop:
✅ Leveraging vascularized microphysiological technology to construct a perfusable, highly stable functional vascular network, breaking through the bottleneck of traditional models lacking physiological vascular perfusion, making tumor-vascular material exchange and signal transmission closer to in vivo conditions;
✅ Seamlessly integrating immune microenvironment reconstruction technology, introducing patient-derived immune cells to construct a "tumor-vascular-immune" three-dimensional microenvironment, further restoring the complex microenvironmental characteristics of clinical lung cancer;
✅ Paired with AI intelligent analysis technology, using digital dynamic algorithms to analyze data from microscopic equipment and proprietary software, achieving precise quantitative analysis of indicators such as tumor morphology, vascular density, and vascular degeneration degree, automatically generating data reports, making the research results of tumor-vascular interactions more objective and accurate.
Say goodbye to traditional limitations and usher in a new era of precision in lung cancer research
Traditional lung cancer research models (such as 2D cell line cultures, ordinary organoid models) suffer from issues like lack of vascular microenvironment, inability to reflect tumor-vascular interactions, and low clinical relevance, leading to difficulties in translating research findings. Animal models, on the other hand, have drawbacks such as species differences, long study periods, and high costs.
Xianjue Bio's lung cancer organoid vascularization model retains the advantages of organoids being "derived from humans and highly biomimetic," while also addressing the microenvironmental shortcomings through vascularization technology. It achieves high matching between in vitro models and clinical lung cancer pathological features, while also offering short experimental cycles, reproducibility, and high throughput, perfectly compensating for the deficiencies of traditional models.
From basic mechanism research to innovative drug development, from treatment plan optimization to personalized precision medicine, Xianjue Bio's lung cancer organoid vascularization model, with its precise replication of tumor-vascular interactions, provides a novel technological pathway for lung cancer research, helping researchers unlock more possibilities in lung cancer diagnosis and treatment!
For precise research on lung cancer tumor and vascular interactions, choose Xianjue Bio's lung cancer organoid vascularization model, making your research closer to clinical practice and more valuable for translation!